Trademark: 97266471
Word
SYNCORX
Status
Pending
Status Code
731
Status Date
Thursday, May 2, 2024
Serial Number
97266471
Mark Type
4
Filing Date
Monday, February 14, 2022
Published for Opposition
Tuesday, March 7, 2023

Trademark Owner History
Astellas Pharma Inc. - Owner At Publication

Classifications
9 Downloadable computer application software for use with web-based platforms and mobile devices in the nature of tablet computers, PDAs and mobile phones, namely, downloadable software for use in accessing a patient's implanted medical device data and transmitting information in the nature of diagnosis of disease, the self-management of symptoms and disabilities, the real-time monitoring of physical and biological indicators, the management of complex medication regimens in order to maintain proper levels of nutrition, diet or exercise which embodies a patient-centric approach for early disease detection whilst aiding and fostering a closer interaction between patients and healthcare providers

Trademark Events
Feb 17, 2022
New Application Entered
Feb 18, 2022
New Application Office Supplied Data Entered
Nov 29, 2022
Assigned To Examiner
Dec 6, 2022
Non-Final Action Written
Dec 6, 2022
Non-Final Action E-Mailed
Dec 6, 2022
Notification Of Non-Final Action E-Mailed
Jan 24, 2023
Teas Response To Office Action Received
Jan 24, 2023
Correspondence Received In Law Office
Jan 24, 2023
Teas/Email Correspondence Entered
Jan 27, 2023
Approved For Pub - Principal Register
Mar 7, 2023
Published For Opposition
Mar 7, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 15, 2023
Notification Of Notice Of Publication E-Mailed
May 2, 2023
Noa E-Mailed - Sou Required From Applicant
Nov 1, 2023
Sou Teas Extension Received
Nov 1, 2023
Sou Extension 1 Filed
Nov 1, 2023
Sou Extension 1 Granted
Nov 3, 2023
Notice Of Approval Of Extension Request E-Mailed
May 2, 2024
Sou Extension 2 Filed
May 2, 2024
Sou Teas Extension Received
May 2, 2024
Sou Extension 2 Granted
May 3, 2024
Notice Of Approval Of Extension Request E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24